Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Seattle Genetics Looking To Improve, Replace Standards Of Care

Jan 30 2018

• By Mandy Jackson

Cancer-cells-pink-color_1200x675

Related Content

INTERVIEW: I-SPY 2 investigator on cancer study, Synta's ganetespib

Mar 13 2014

BioNotebook: Seattle Genetics/AbbVie, Auspex, Flexion, Ironwood

Jan 09 2014

ASH In Review: Roche Refreshes Hematology Portfolio With Robust New Drugs

Dec 16 2017

And Then There Were Five: Roche's Tecentriq Joins Europe I-O Race

Sep 27 2017

GSK's Oncology R&D Head: GSK2857916 'Proves We're Still Here And Serious'

Nov 02 2017

A CASCADE Of Trouble For Seattle Genetics' AML Drug SGN-CD33A

Jun 19 2017

The Bar Is Raised At ASCO For ADC Developers

Jun 05 2017

Related Companies

Seagen Inc.

Takeda Pharmaceutical Co. Ltd.

Astellas Pharma, Inc.

Merck & Co., Inc.

Roche Holding AG

AstraZeneca PLC

Merck KGaA

Pfizer Inc.

Genmab A/S

GSK plc

Genentech, Inc.

AbbVie Inc.

Additional Topics

Business Strategies Companies Commercial Cancer BioPharmaceutical

More from Strategy

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window